Download PDF
Dtsch Med Wochenschr 2014; 139(33): 1673-1678
DOI: 10.1055/s-0034-1370199
Prinzip & Perspektive | Review article
Hämatologie
© Georg Thieme Verlag KG Stuttgart · New York

Mikro-RNA: Rolle bei der Immunregulation nach allogener hämatopoetischer Stammzelltransplantation

The role of microRNAs for immunoregulation after allogeneic hematopoietic cell transplantation
N. Stickel
1   Klinik für Innere Medizin I, Hämatologie, Onkologie und Stammzelltransplantation, Universitätsklinikum Freiburg
2   Spemann Graduiertenschule für Biologie und Medizin, Albert-Ludwigs-Universität Freiburg
3   Fakultät für Biologie, Albert-Ludwigs-Universität Freiburg
,
R. Zeiser
1   Klinik für Innere Medizin I, Hämatologie, Onkologie und Stammzelltransplantation, Universitätsklinikum Freiburg
› Author Affiliations
Further Information

Publication History

30 April 2014

08 May 2014

Publication Date:
05 August 2014 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Immunregulation nach allogener hämatopoetischer Stammzelltransplantation (allo-HSZT) beschreibt das empfindliche Gleichgewicht zwischen dem erwünschten Transplantat-gegen-Leukämie Effekt (GvL) und der Vermeidung der unerwünschten Transplantat-gegen-Wirt-Reaktion (GvHD). Bei verschiedenen entzündlichen und malignen Erkrankungen wurde bereits über eine Rolle von Mikro-RNA (miRNA) berichtet. Insbesondere bei Autoimmunerkrankungen, Allergien und GvHD findet man häufig eine dysregulierte Expression verschiedener miRNA. Der Artikel soll eine Übersicht über aktuelle Erkenntnisse zur Rolle von miRNA bei der Immunregulation nach allo-HSZT darstellen und einen Ausblick auf neue potenzielle diagnostische und therapeutische Möglichkeiten wie beispielsweise die Nutzung von miRNA im Serum als Biomarker oder die Modifikation einer Immunantwort durch miRNA Mimetics geben.

Abstract

Immunoregulation following allogeneic hematopoietic stem cell transplantation (allo-HSCT) involves the delicate balance between the desirable graft-versus-leukemia (GvL) effect and the prevention of the undesirable graft-versus-host disease (GvHD). Emerging evidence has shown that microRNAs (miRNAs) play a role in the pathogenesis of different inflammatory and malignant diseases. Especially in autoimmune diseases, allergy and GvHD numerous dysregulated miRNAs have been identified. In this review, we provide an overview of current knowledge about the role of miRNAs in the immunoregulation after allo-HSCT. Moreover, we give an outlook on potential new diagnostic and therapeutic approaches, including the use of miRNAs as clinical biomarkers and the manipulation of immune responses using miRNA mimetics.

Schlüsselwörter

Mikro-RNA - Immunregulation - Transplantat gegen Wirt Reaktion - Graft-versus-host disease (GvHD) - allogene hämatopoetische Stammzelltransplantation

Key words

microRNA - Immunoregulation - Graft-versus-host disease (GvHD) - allogeneic hematopoietic stem cell transplantation
 

  • Literatur

  • 1 Allegra A, Alonci A, Campo S et al. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Intern J Oncol 2012; 41: 1897-1912
    PubMedSearch in Google Scholar
  • 2 Androulidaki A, Iliopoulos D, Arranz A et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009; 31: 220-231
    CrossrefPubMedSearch in Google Scholar
  • 3 Atarod S, Dickinson AM. MicroRNAs: The Missing Link in the Biology of Graft-Versus-Host Disease?. Front Immunol 2013; 4: 420
    PubMedSearch in Google Scholar
  • 4 Baltimore D, Boldin MP, O'Connell RM et al. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008; 8: 839-845
    PubMedSearch in Google Scholar
  • 5 Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nature Rev Immuno 2012; 12: 443-458
    PubMedSearch in Google Scholar
  • 6 Boldin MP, Taganov KD, Rao DS et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 2011; 208: 1189-1201
    CrossrefPubMedSearch in Google Scholar
  • 7 Bousquet M, Quelen C, Rosati R et al. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 2008; 205: 2499-2506
    CrossrefPubMedSearch in Google Scholar
  • 8 Brunstein CG, Miller JS, Cao Q et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011; 117: 1061-1070
    CrossrefPubMedSearch in Google Scholar
  • 9 Chong MM, Rasmussen JP, Rudensky AY et al. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 2008; 205: 2005-2017
    CrossrefPubMedSearch in Google Scholar
  • 10 Cobb BS, Nesterova TB, Thompson E et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 2005; 201: 1367-1373
    CrossrefPubMedSearch in Google Scholar
  • 11 Cohen JL, Trenado A, Vasey D et al. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002; 196: 401-406
    CrossrefPubMedSearch in Google Scholar
  • 12 Du C, Liu C, Kang J et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nature Immunol 2009; 10: 1252-1259
    CrossrefPubMedSearch in Google Scholar
  • 13 Hechinger AK, Maas K, Dürr C et al. Inhibition of protein geranylgeranylation and farnesylation protects against GvHD via effects on CD4 effector T cells. Haematologica 2013; 98: 31-40
    CrossrefPubMedSearch in Google Scholar
  • 14 Hoffmann P, Ermann J, Edinger M et al. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389-399
    CrossrefPubMedSearch in Google Scholar
  • 15 Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009; 139: 693-706
    CrossrefPubMedSearch in Google Scholar
  • 16 Jankovic D, Ganesan J, Bscheider M et al. The Nlrp3-inflammasome regulates acute graft-versus-host disease. J Exp Med 2013; 210: 1899-1910
    CrossrefPubMedSearch in Google Scholar
  • 17 Janssen HL, Reesink HW, Lawitz EJ et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368: 1685-1694
    CrossrefPubMedSearch in Google Scholar
  • 18 Junker A. Pathophysiology of translational regulation by microRNAs in multiple sclerosis. FEBS letters 2011; 585: 3738-3746
    CrossrefPubMedSearch in Google Scholar
  • 19 Keller A, Leidinger P, Lange J et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009; 4: e7440
    CrossrefPubMedSearch in Google Scholar
  • 20 Koralov SB, Muljo SA, Galler GR et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132: 860-874
    CrossrefPubMedSearch in Google Scholar
  • 21 Kurowska-Stolarska M, Alivernini S, Ballantine LE et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 2011; 108: 11193-11198
    CrossrefPubMedSearch in Google Scholar
  • 22 Lagos-Quintana M, Rauhut R, Lendeckel W et al. Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-858
    CrossrefPubMedSearch in Google Scholar
  • 23 Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854
    CrossrefPubMedSearch in Google Scholar
  • 24 Lee Y, Kim M, Han J et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051-4060
    CrossrefPubMedSearch in Google Scholar
  • 25 Leonhardt F, Grundmann S, Behe M et al. Inflammatory neovascularization during graft-versus-host disease is regulated by αv integrin and miR-100. Blood 2013; 121: 3307-3318
    CrossrefPubMedSearch in Google Scholar
  • 26 Leonhardt F, Zirlik K, Buchner M et al. Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels. Leukemia 2012; 26: 1617-1629
    CrossrefPubMedSearch in Google Scholar
  • 27 Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20
    CrossrefPubMedSearch in Google Scholar
  • 28 Li J, Wan Y, Guo Q et al. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arth Res Ther 2010; 12: R81
    CrossrefPubMedSearch in Google Scholar
  • 29 Li QJ, Chau J, Ebert PJ et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147-161
    CrossrefPubMedSearch in Google Scholar
  • 30 Lim LP, Lau NC, Garrett-Engele P et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773
    CrossrefPubMedSearch in Google Scholar
  • 31 Liston A, Lu LF, O'Carroll D et al. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 2008; 205: 1993-2004
    CrossrefPubMedSearch in Google Scholar
  • 32 Muljo SA, Ansel KM, Kanellopoulou C et al. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005; 202: 261-269
    CrossrefPubMedSearch in Google Scholar
  • 33 Murata K, Yoshitomi H, Tanida S et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arth Res Ther 2010; 12: R86
    CrossrefPubMedSearch in Google Scholar
  • 34 Niimoto T, Nakasa T, Ishikawa M et al. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskel Dis 2010; 11: 209
    CrossrefPubMedSearch in Google Scholar
  • 35 O'Connell RM, Chaudhuri AA, Rao DS et al. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 2009; 106: 7113-7118
    CrossrefPubMedSearch in Google Scholar
  • 36 O'Connell RM, Kahn D, Gibson WS et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010; 33: 607-619
    CrossrefPubMedSearch in Google Scholar
  • 37 O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nature Rev Immunol 2011; 11: 163-175
    CrossrefPubMedSearch in Google Scholar
  • 38 Otaegui D, Baranzini SE, Armananzas R et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009; 4: e6309
    CrossrefPubMedSearch in Google Scholar
  • 39 Penack O, Henke E, Suh D et al. Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. J Natl Cancer Inst 2010; 102: 894-908
    CrossrefPubMedSearch in Google Scholar
  • 40 Ponomarev ED, Veremeyko T, Barteneva N et al. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nature Med 2011; 17: 64-70
    CrossrefPubMedSearch in Google Scholar
  • 41 Qiu Z, Dai Y. Roadmap of miR-122-related clinical application from bench to bedside. Expert Opin Investig Drugs 2014; 3: 347-355
    PubMedSearch in Google Scholar
  • 42 Ranganathan P, Heaphy CE, Costinean S et al. Regulation of acute graft-versus-host disease by microRNA-155. Blood 2012; 119: 4786-4797
    CrossrefPubMedSearch in Google Scholar
  • 43 Reinhart BJ, Slack FJ, Basson M et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403: 901-906
    CrossrefPubMedSearch in Google Scholar
  • 44 Rodriguez A, Griffiths-Jones S, Ashurst JL et al. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004; 14: 1902-1910
    CrossrefPubMedSearch in Google Scholar
  • 45 Rodriguez A, Vigorito E, Clare S et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316: 608-611
    CrossrefPubMedSearch in Google Scholar
  • 46 Schwab L, Goroncy L, Palaniyandi S et al. Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance GvHD via tissue damage. Nat Med 2014; in press
    PubMedSearch in Google Scholar
  • 47 Sheedy FJ, Palsson-McDermott E, Hennessy EJ et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nature Immunol 2010; 11: 141-147
    CrossrefPubMedSearch in Google Scholar
  • 48 Stanczyk J, Pedrioli DM, Brentano F et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arth Rheum 2008; 58: 1001-1009
    CrossrefPubMedSearch in Google Scholar
  • 49 Stittrich AB, Haftmann C, Sgouroudis E et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nature Immunol 2010; 11: 1057-1062
    CrossrefPubMedSearch in Google Scholar
  • 50 Taganov KD, Boldin MP, Chang KJ et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006; 103: 12481-12486
    CrossrefPubMedSearch in Google Scholar
  • 51 Thai TH, Calado DP, Casola S et al. Regulation of the germinal center response by microRNA-155. Science 2007; 316: 604-608
    CrossrefPubMedSearch in Google Scholar
  • 52 Thompson LF, Tsukamoto H, Chernogorova P et al. A delicate balance: CD73-generated adenosine limits the severity of graft vs. host disease but also constrains the allogeneic graft vs. tumor effect. Oncoimmunology 2013; 2: e22107
    CrossrefPubMedSearch in Google Scholar
  • 53 Tili E, Michaille JJ, Cimino A et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179: 5082-5089
    CrossrefPubMedSearch in Google Scholar
  • 54 Velu CS, Chaubey A, Phelan JD et al. Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity. J Clin Invest 2014; 124: 222-236
    CrossrefPubMedSearch in Google Scholar
  • 55 Wang L, Romero M, Ratajczak P et al. Increased apoptosis is linked to severe acute GVHD in patients with Fanconi anemia. Bone Marrow Transplant 2013; 48: 849-853
    CrossrefPubMedSearch in Google Scholar
  • 56 Wilhelm K, Ganesan J, Müller T et al. Graft-versus-host disease enhanced by extracellular adenosine triphosphate activating P2X7R. Nature Med 2010; 12: 1434-1438
    PubMedSearch in Google Scholar
  • 57 Xiao B, Wang Y, Li W et al. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease. Blood 2013; 122: 3365-3375
    CrossrefPubMedSearch in Google Scholar
  • 58 Xie LN, Zhou F, Liu XM et al. Serum microRNA155 is increased in patients with acute graft-versus-host disease. Clin Transplant 2014; 28: 314-323
    CrossrefPubMedSearch in Google Scholar
  • 59 Yang L, Boldin MP, Yu Y et al. miR-146a controls the resolution of T cell responses in mice. J Exp Med 2012; 209: 1655-1670
    CrossrefPubMedSearch in Google Scholar